树突细胞在NSCLC中的新兴机制和治疗潜力
Jing Zhou1, Ling Zhao1, Lianfang Liu2
1Department of Laboratory Medicine, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang Hospital of Traditional Chinese Medicine, Zhangjiagang, Jiangsu, People's Republic of China.
Journal of inflammation research
|April 21, 2025
概括
树突细胞 (DCs) 在非小细胞肺癌 (NSCLC) 中至关重要. 本综述详细介绍了DC功能和高级NSCLC的新疗法策略,提供了新的治疗可能性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
背景情况:
- 非小细胞肺癌 (NSCLC) 是主要的肺癌类型.
- 尽管目前使用化疗,放射治疗和免疫治疗等治疗方法,但高级NSCLC患者的预后不佳.
- 树突细胞 (DCs),强效抗原呈现细胞 (APCs),显著影响NSCLC瘤微环境 (TME).
研究的目的:
- 审查NSCLC中树突细胞 (DC) 的分类和生物功能.
- 突出分子路径和影响NSCLC中DC成熟和功能的外部因素.
- 探索DCs用于管理NSCLC的新型治疗应用.
主要方法:
- 关于树突细胞和非小细胞肺癌的科学文章的文献综述.
- 对NSCLC TME中影响DC功能的分子通路和外部因素的分析.
- 讨论目前和潜在的未来基于直流的NSCLC免疫疗法.
主要成果:
- DC在NSCLC瘤微环境中起着至关重要的作用.
- 特定的分子通路和外部因素影响NSCLC中的DC成熟和功能.
- 基于直流的疗法为先进的NSCLC治疗提供了有前途的途径.
结论:
- 了解NSCLC中DC生物学对于开发有效的免疫疗法至关重要.
- 针对DCs为改善NSCLC患者的治疗结果提供了新的治疗机会.
- 进一步研究基于直流的策略可能会彻底改变NSCLC的管理.
更多相关视频
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.3K
11:48Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
11.3K
相关概念视频
Cytotoxic T Cells-mediated Immune Response
725
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
725
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Tumor Immunotherapy
398
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
398
